NCT07463677 2026-03-11
Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
Sun Yat-sen University
University of Maryland, Baltimore
Kaohsiung Medical University
Tata Memorial Hospital
Jonsson Comprehensive Cancer Center
All India Institute of Medical Sciences
St. Jude Children's Research Hospital